CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Aventis Pharma S.A. v. Hospira, Inc.

2:07-cv-08137

Overview

Case Number 2:07-cv-08137
Filing Date 2007-12-14
Status Terminated
Termination Date 2008-07-31
Court District Court, C.D. California (cacd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Hospira, Inc. Operating Company

Represented By

5 Attorneys Listed

Daniel C Whang

Russ August and Kabat

Tel: +1 (310) 826-7474
Fax: +1 (310) 826-6991

Russ August and Kabat, 12424 Wilshire Boulevard 12th Floor

Kathleen B Barry

WINSTON & STRAWN LLP

Tel: +1 (312) 558-8046

35 W. Wacker Drive, Chicago, IL 60601-9703

James F Hurst

Winston and Strawn

Tel: +1 (312) 558-5600
Fax: +1 (312) 558-5700

Winston and Strawn, 35 West Wacker Drive

Gail Jeanne Standish

Winston and Strawn LLP

Tel: +1 (213) 615-1700
Fax: +1 (213) 615-1750

333 South Grand Avenue 38th Floor, Los Angeles, CA 90071-1543

Charles B. Klein

WINSTON & STRAWN LLP

Tel: +1 (202) 282-5000
Fax: +1 (202) 282-5100

1700 K. Street, N.W., Washington, DC 20006-3817

Plaintiff

Aventis Pharmaceuticals Inc. Operating Company

Represented By

5 Attorneys Listed

Robert C Stanley

Finnegan Henderson Farabow Garrett & Dunner LLP

Tel: +1 (404) 653-6400

3500 SunTrust Plaza, 303 Peachtree Street N E

Erik Raymond Puknys

Finnegan Henderson Farabow Garrett & Dunner

Tel: +1 (650) 849-6600

Finnegan Henderson Farabow Garrett & Dunner, Stanford Research Pk

Donald L Ridge

Morris Polich and Purdy LLP

Tel: +1 (213) 417-5117
Fax: +1 (213) 488-1178

1055 West 7th Street Suite 2400, Los Angeles, CA 90017-2503

Donald R. Dunner

Finnegan Henderson Farabow Garrett & Dunner

Tel: +1 (202) 408-4062
Fax: +1 (202) 408-4400

Finnegan Henderson Farabow Garrett & Dunner, 901 New York Avenue NW

Allen M Sokal

Finnegan Henderson Farabow Garrett and Dunner

Tel: +1 (202) 408-4014

Finnegan Henderson Farabow Garrett and Dunner, 901 New York Avenue NW

Aventis Pharma S.A. NPE (Individual / Inventor)

Represented By

5 Attorneys Listed

Robert C Stanley

Finnegan Henderson Farabow Garrett & Dunner LLP

Tel: +1 (404) 653-6400

3500 SunTrust Plaza, 303 Peachtree Street N E

Erik Raymond Puknys

Finnegan Henderson Farabow Garrett & Dunner

Tel: +1 (650) 849-6600

Finnegan Henderson Farabow Garrett & Dunner, Stanford Research Pk

Donald L Ridge

Morris Polich and Purdy LLP

Tel: +1 (213) 417-5117
Fax: +1 (213) 488-1178

1055 West 7th Street Suite 2400, Los Angeles, CA 90017-2503

Donald R. Dunner

Finnegan Henderson Farabow Garrett & Dunner

Tel: +1 (202) 408-4062
Fax: +1 (202) 408-4400

Finnegan Henderson Farabow Garrett & Dunner, 901 New York Avenue NW

Allen M Sokal

Finnegan Henderson Farabow Garrett and Dunner

Tel: +1 (202) 408-4014

Finnegan Henderson Farabow Garrett and Dunner, 901 New York Avenue NW

Court & Judges

Court

District Court, C.D. California (cacd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): FR 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5389618
Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
Filed: 1993-07-16
Issued: 1995-02-14
Expired (Term Ended)
Expires: 2013-07-16

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(73 total)
Pleading / Complaint

COMPLAINT against Defendant Hospira, Inc. (Filing fee $ 350 PAID.), filed by Plaintiffs Aventis Pharma S.A., Aventis Pharmaceuticals Inc. (et) Additional attachment(s) added on 12/26/2007 (lra, ). (Entered: 12/23/2007)

Entry #1 • 2007-12-14
1

NOTICE of Interested Parties filed by Plaintiffs Aventis Pharma S.A., Aventis Pharmaceuticals Inc. (et) Additional attachment(s) added on 12/26/2007 (lra, ). (Entered: 12/23/2007)

Entry #2 • 2007-12-14
1

NOTICE TO PARTIES OF ADR PILOT PROGRAM filed. (et) (Entered: 12/23/2007)

Entry #3 • 2007-12-14
1

REPORT ON THE FILING OF AN ACTION Regarding a Patent or a Trademark (Initial Notification) filed by Aventis Pharma S.A., Aventis Pharmaceuticals Inc. (et) (Entered: 12/23/2007)

Entry #4 • 2007-12-14
1

NOTICE of Related Case(s) filed by Plaintiffs Aventis Pharma S.A., Aventis Pharmaceuticals Inc.. Related Case(s): EDCV 03-887 MRP (PLAx), EDCV 04-333 MRP (PLAx), CV 06-4858 MRP (PLAx), CV 07-3658 MRP (PLAx) (rn) (Entered: 12/27/2007)

Entry #5 • 2007-12-14
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc